Based in Phoenix, Arizona, TGen’s mission is to translate research discoveries into improved diagnostics and therapies, shortening the path from scientific discovery to improved patient outcomes.Continue reading
Category Archives: AZBio News
How do different dementia pathologies interact in the mouse brain?
TGen-led study clarifies interactions between amyloid, tau, alpha-synuclein proteins
C-Path Awards $250,000 Grant to Advance New Treatment for Sepsis-Associated Neurocognitive Dysfunction
TUCSON, Ariz., July 9, 2026 — Critical Path Institute® (C-Path) has awarded a $250,000 research grant to Teresa Sanchez, Ph.D., of Weill Cornell Medicine, to support the development of a novel therapeutic approach for sepsis-associated neurocognitive dysfunction.Continue reading
Partnership Creates a Bridge Between Arizona and Taiwan Life Science Communities
The Arizona Bioindustry Association, Inc. (AZBio) and Bio Taiwan execute a Memorandum of Understanding focused on fostering collaborations between organizations in the Arizona and Taiwan life science sectors at the 2026 BIO International Convention in San Diego.
AZBio Member Spotlight – Valley Fever Solutions
Based in Arizona, Valley Fever Solutions is focused on resolving valley fever and from there, expanding to treat fungal infections more broadly, with a vision to redefine treatment standards in fungal disease.Continue reading
AZBio Member Spotlight – ImmunoShield Therapeutics
Based in Arizona, ImmunoShield Therapeutics is working to turn the long-promised curative potential of allogeneic cell therapies into a reality, starting with type 1 diabetes.Continue reading
GT Medical Technologies Completes Oversubscribed $100 Million Series E Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
Financing round led by new investor Viking Global Investors with participation from key existing investorsContinue reading
C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes
Regulatory milestone underscores opportunity for shared regulatory-science and evidence frameworks to support the next generation of therapies.Continue reading
AZBio Member Spotlight – Aces Diagnostics
Aces Diagnostics is focused on solving one of the biggest gaps in infectious disease diagnostics: the lack of accurate testing for Lyme disease.Continue reading
C-Path Appoints Biotech Executive and Investor Dr. Milad Alucozai to Board of Directors
TUCSON, Ariz., June 11, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Milad Alucozai, DrPH, MPH, M.Sc., to its Board of Directors.Continue reading